Thrombosis et diathesis haemorrhagica, 0340-6245

Tidskrift

Fler filtreringsmöjligheter
  1. A common origin of the 4143insA ADAMTS13 mutation

    Schneppenheim, R., Hovinga, J. A. K., Becker, J., Budde, U., Diana Karpman, Brockhaus, W., Hrachovinova, I., Korczowski, B., Oyen, F., Rittich, S., von Rosen, J., Tjonnfjord, G. E., Pimanda, J. E., Wienker, T. F. & Laemmle, B., 2006, I : Thrombosis and Haemostasis. 96, 1, s. 3-6

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  2. A common thrombomodulin amino acid dimorphism is associated with myocardial infarction

    Norlund, L., Johan Holm, Bengt Zöller & Öhlin, A-K., 1997 feb, I : Thrombosis and Haemostasis. 77, 2, s. 248-51

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  3. Activation of human polymorphonuclear neutrophils by streptolysin O from Streptococcus pyogenes leads to the release of proinflammatory mediators.

    Nilsson, M. E., Ole E Sørensen, Mörgelin, M., Weineisen, M., Sjöbring, U. & Heiko Herwald, 2006, I : Thrombosis and Haemostasis. 95, 6, s. 982-990

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  4. Active but inoperable thrombin is accumulated in a plasma protein layer surrounding Streptococcus pyogenes.

    Naudin, C., Hurley, S., Erik Malmström, Plug, T., Oonagh Shannon, Meijers, J. C. M., Mörgelin, M., Lars Björck & Heiko Herwald, 2015, I : Thrombosis and Haemostasis. 114, 4, s. 717-726

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  5. A Genome-wide Study of Common and Rare Genetic Variants Associated with Circulating Thrombin Activatable Fibrinolysis Inhibitor

    Stanne, T. M., Olsson, M., Lorentzen, E., Pedersen, A., Gummesson, A., Gils, A., Jood, K., Gunnar Engström, Olle Melander, Declerck, P. J. & Jern, C., 2018, I : Thrombosis and Haemostasis. 118, 2, s. 298-308

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  6. A large deletion identified in a Swedish family with type 1 VWD

    Johansson, A. M., Lanke, E., Torbjörn Säll, Lethagen, S. & Halldén, C., 2011, I : Thrombosis and Haemostasis. 105, 4, s. 733-734

    Forskningsoutput: TidskriftsbidragLetter

  7. Amino acid residues in the laminin G domains of protein S involved in tissue factor pathway inhibitor interaction.

    Somajo, S., Ahnström, J., Fernandez-Recio, J., Gierula, M., Villoutreix, B. O. & Björn Dahlbäck, 2015, I : Thrombosis and Haemostasis. 113, 5, s. 976-987

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  8. Analytical considerations for free protein S assays in protein S deficiency

    Kristina Persson, Andreas Hillarp & Björn Dahlbäck, 2001, I : Thrombosis and Haemostasis. 86, 5, s. 1144-1147

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  9. A new direct, fast and quantitative enzyme-linked ligandsorbent assay for measurement of free protein S antigen

    Giri, T. K., Andreas Hillarp, Härdig, Y., Bengt Zöller & Björn Dahlbäck, 1998, I : Thrombosis and Haemostasis. 79, 4, s. 767-772 6 s.

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  10. A novel thrombomodulin gene mutation in a patient suffering from sagittal sinus thrombosis

    Norlund, L., Bengt Zöller & Öhlin, A-K., 1997 okt, I : Thrombosis and Haemostasis. 78, 4, s. 1164-1166 3 s.

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  11. Anti-inflammatory, anti-coagulant, anti-biotic?

    Heiko Herwald, 2013, I : Thrombosis and Haemostasis. 109, 4, s. 582-582

    Forskningsoutput: TidskriftsbidragDebate/Note/Editorial

  12. Antimicrobial activity of fibrinogen and fibrinogen-derived peptides - a novel link between coagulation and innate immunity.

    Lisa Påhlman, Mörgelin, M., Kasetty, G., Olin, A., Artur Schmidtchen & Heiko Herwald, 2013, I : Thrombosis and Haemostasis. 109, 5, s. 930-939

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  13. Antithrombotic effect of recombinant truncated tissue factor pathway inhibitor (TFPI1-161) in experimental venous thrombosis: A comparison with low molecular weight heparin

    J. Holst, Lindblad, B., Bergqvist, D., Nordfang, O., Ostergaard, P. B., Petersen, J. G. L., Nielsen, G. & Hedner, U., 1994, I : Thrombosis and Haemostasis. 71, 2, s. 214-219

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  14. Binding characteristics of thrombin-activatable fibrinolysis inhibitor to streptococcal surface collagen-like proteins A and B

    Seron, M. V., Plug, T., Marquart, J. A., Marx, P. F., Heiko Herwald, de Groot, P. G. & Meijers, J. C. M., 2011, I : Thrombosis and Haemostasis. 106, 4, s. 609-616

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  15. Binding of vitronectin and Factor H to Hic contributes to immune evasion of Streptococcus pneumoniae serotype 3.

    Kohler, S., Hallström, T., Singh, B., Kristian Riesbeck, Sparta, G., Zipfel, P. F. & Hammerschmidt, S., 2015, I : Thrombosis and Haemostasis. 113, 1, s. 125-142

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  16. Bleeding complications and mortality in warfarin-treated VTE patients, dependence of INR variability and iTTR

    Sandén, P., Renlund, H., Peter J. Svensson & Själander, A., 2017 jan 1, I : Thrombosis and Haemostasis. 117, 1, s. 27-32 6 s.

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  17. BRCA2 gene mutations and coagulation-associated biomarkers

    Perez-Segura, P., Zamorano-León, J. J., Acosta, D., Santos-Sancho, J. M., Modrego, J., Caldés, T., De La Hoya, M., Díaz-Rubio, E., Díaz-Millán, I., De Las Heras, N., Zalba, L. A. R., Lahera, V., Olle Melander & Farré, A. L., 2016, I : Thrombosis and Haemostasis. 115, 2, s. 415-423 9 s.

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  18. B regulatory cells are increased in hypercholesterolaemic mice and protect from lesion development via IL-10

    Strom, A. C., Cross, A. J., Cole, J. E., Blair, P. A., Leib, C., Goddard, M. E., Rosser, E. C., Park, I., Nilsson, A. H., Jan Nilsson, Mauri, C. & Monaco, C., 2015, I : Thrombosis and Haemostasis. 114, 4, s. 835-847

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  19. Characterization of a novel mutation in the von Willebrand factor propeptide in a distinct subtype of recessive von Willebrand disease.

    Lanke, E., Ann-Charlotte Kristoffersson, Philips, M., Lars Holmberg & Lethagen, S., 2008, I : Thrombosis and Haemostasis. 100, 2, s. 211-216

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  20. Clopidogrel metaboliser status based on point-of-care CYP2C19 genetic testing in patients with coronary artery disease.

    David Erlinge, James, S., Duvvuru, S., Jakubowski, J. A., Wagner, H., Varenhorst, C., Tantry, U. S., Brown, P. B., Small, D., Moser, B. A., Sundseth, S., Walker, J. R., Winters, K. J. & Gurbel, P. A., 2014, I : Thrombosis and Haemostasis. 111, 5, s. 943-950

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  21. Coagulation factorV and thrombophilia: Background and mechanisms

    Segers, K., Björn Dahlbäck & Nicolaes, G. A. F., 2007, I : Thrombosis and Haemostasis. 98, 3, s. 530-542

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  22. Coagulation factor XIII: a multifunctional transglutaminase with clinical potential in a range of conditions

    Dickneite, G., Heiko Herwald, Korte, W., Allanore, Y., Denton, C. P. & Cerinic, M. M., 2015, I : Thrombosis and Haemostasis. 113, 4, s. 686-697

    Forskningsoutput: TidskriftsbidragÖversiktsartikel

  23. Combined effect of factor V Leiden and prothrombin 20210A on the risk of venous thromboembolism - Pooled analysis of 8 case-control studies including 2310 cases and 3204 controls

    Emmerich, J., Rosendaal, F. R., Cattaneo, M., Margaglione, M., De Stefano, V., Cumming, T., Arruda, V., Andreas Hillarp & Reny, J-L., 2001, I : Thrombosis and Haemostasis. 86, 3, s. 809-816

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  24. Control of smooth muscle cell proliferation - The role of the basement membrane

    Hedin, U., Roy, J., Tran, P. K., K. Lundmark & Rahman, A., 1999 dec 1, I : Thrombosis and Haemostasis. 82, SUPPL. 1, s. 23-26 4 s.

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  25. Diabetes duration may modify the association between genetic variation in the glycoprotein la subunit of the platelet collagen receptor and risk of severe diabetic retinopathy: a working hypothesis

    Reiner, AP., Elisabet Agardh, Teramura, G., Gaur, P., Gaur, LK. & Agardh, C-D., 2003, I : Thrombosis and Haemostasis. 89, 1, s. 142-148

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  26. Diagnostic potential of plasma microRNA signatures in patients with deep-vein thrombosis

    Xiao Wang, Kristina Sundquist, Johan L. Elf, Strandberg, K., Peter J. Svensson, Hedelius, A., Palmér, K., Ashfaque A. Memon, Jan Sundquist & Bengt Zöller, 2016 aug 1, I : Thrombosis and Haemostasis. 116, 2, s. 328-336 9 s.

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  27. Distribution of von Willebrand factor levels in young women with and without bleeding symptoms. Influence of ABO blood group and promoter haplotypes

    Lethagen, S., Andreas Hillarp, Ekholm, C., Mattson, E., Halldén, C. & Britt Friberg, 2008, I : Thrombosis and Haemostasis. 99, 6, s. 1013-1018

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  28. Effect of low molecular weight heparin, dextran and their combinations on experimental venous thrombosis in rabbits

    Matthiasson, S. E., Lindblad, B., Mätzsch, T., Jan Holst & Bergqvist, D., 1994, I : Thrombosis and Haemostasis. 71, 3, s. 363-365

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  29. Effects of an enzymatically depolymerized heparin as compared with conventional heparin in healthy volunteers

    Mätzsch, T., Bergqvist, D., Hedner, U. & Ostergaard, P., 1987, I : Thrombosis and Haemostasis. 57, 1, s. 97-101

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  30. Effects of low molecular weight heparin and unfragmented heparin on induction of osteoporosis in rats

    Mätzsch, T., Bergqvist, D., Hedner, U., Nilsson, B. & Ostergaard, P., 1990, I : Thrombosis and Haemostasis. 63, 3, s. 505-509

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  31. Enhanced active metabolite generation and platelet inhibitionwith prasugrel compared to clopidogrel regardless of genotype in thienopyridine metabolic pathways.

    Oscar Braun, Angiolillo, D. J., Ferreiro, J. L., Jakubowski, J. A., Winters, K. J., Effron, M. B., Duvvuru, S., Costigan, T. M., Sundseth, S., Walker, J. R., Saucedo, J. F., Kleiman, N. S. & Varenhorst, C., 2013, I : Thrombosis and Haemostasis. 110, 6, s. 1223-1231

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  32. Experimental haemorrhagic effect of two-domain non-glycosylated tissue factor pathway inhibitor compared to low molecular weight heparin

    Jan Holst, Lindblad, B., Matthíasson, S. E., Stjernquist, U., Ezban, M., Østergaard, P. B. & Hedner, U., 1996 apr, I : Thrombosis and Haemostasis. 75, 4, s. 585-589

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  33. Extracellular nucleic acids in immunity and cardiovascular responses: Between alert and disease

    Preissner, K. T. & Heiko Herwald, 2017, I : Thrombosis and Haemostasis. 117, 7, s. 1272-1282 11 s.

    Forskningsoutput: TidskriftsbidragÖversiktsartikel

  34. Extracellular nucleotides ATP and UTP induce a marked acute release of tissue-type plasminogen activator in vivo in man

    Hrafnkelsdottir, T., David Erlinge & Jern, S., 2001, I : Thrombosis and Haemostasis. 85, 5, s. 875-881

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  35. FactorVIIa and its potential therapeutic use in bleeding-associated pathologies

    Hedner, U., 2008, I : Thrombosis and Haemostasis. 100, 4, s. 557-562

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  36. Factor VIIa binding to endothelial cell protein C receptor: Differences between mouse and human systems

    Sen, P., Clark, C. A., Gopalakrishnan, R., Hedner, U., Esmon, C. T., Pendurthi, U. R. & Rao, L. V. M., 2012, I : Thrombosis and Haemostasis. 107, 5, s. 951-961

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  37. Factor V Q506 (resistance to activated protein C) and prognosis after acute coronary syndrome

    Johan Holm, Andreas Hillarp, Bengt Zöller, Erhardt, L. RW., Erik Berntorp & Björn Dahlbäck, 1999, I : Thrombosis and Haemostasis. 81, 6, s. 857-860 4 s.

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  38. Family history of venous thromboembolism as a risk factor and genetic research tool.

    Bengt Zöller, Xinjun Li, Ohlsson, H., Jianguang Ji, Jan Sundquist & Kristina Sundquist, 2015, I : Thrombosis and Haemostasis. 114, 5, s. 890-900

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  39. Farnesyl pyrophosphate is an endogenous antagonist to ADP-stimulated P2Y12 receptor-mediated platelet aggregation.

    Högberg, C., Olof Gidlöf, Deflorian, F., Jacobson, K. A., Abdelrahman, A., Müller, C. E., Björn Olde & David Erlinge, 2012, I : Thrombosis and Haemostasis. 108, 1, s. 119-132

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  40. Fibrin gel structure obtained with a FVIIa analogue with enhanced FX-activating potential in haemophilia

    He, S., Ezban, M., Bark, N., Persson, E. & Hedner, U., 2009, I : Thrombosis and Haemostasis. 102, 4, s. 790-792

    Forskningsoutput: TidskriftsbidragLetter

  41. Fibrinogen measurement in cardiac surgery with cardiopulmonary bypass: Analysis of repeatability and agreement of Clauss method within and between six different laboratories

    Solomon, C., Baryshnikova, E., Tripodi, A., Schlimp, C. J., Schoechl, H., Cadamuro, J., Dag Winstedt, Asmis, L. & Ranucci, M., 2014, I : Thrombosis and Haemostasis. 112, 1, s. 109-117

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  42. Genetic and phenotypic variability between families with hereditary protein S deficiency

    Rezende, SM., Lane, DA., Bengt Zöller, Mille-Baker, B., Laffan, M., Björn Dahlbäck & Simmonds, RE., 2002, I : Thrombosis and Haemostasis. 87, 2, s. 258-265

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  43. Genetic aspects of thrombotic disease

    Garcia de Frutos, P. & Bengt Zöller, 2015, I : Thrombosis and Haemostasis. 114, 5, s. 883-884

    Forskningsoutput: TidskriftsbidragDebate/Note/Editorial

  44. Genetic Variation in the Syntaxin-Binding Protein STXBP5 in Type 1 von Willebrand Disease Patients

    Lind-Halldén, C., Manderstedt, E., Carlberg, D., Lethagen, S. & Halldén, C., 2018 jul 4, I : Thrombosis and Haemostasis.

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  45. Greater reduction of platelet activation markers and platelet-monocyte aggregates by prasugrel compared to clopidogrel in stable coronary artery disease

    Oscar Braun, Johnell, M., Varenhorst, C., James, S., Brandt, J. T., Jakubowski, J. A., Winters, K. J., Wallentin, L., David Erlinge & Siegbahn, A., 2008, I : Thrombosis and Haemostasis. 100, 4, s. 626-633

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  46. Haemostasis, vascular biology, and infectious agents.

    Heiko Herwald, 2007, I : Thrombosis and Haemostasis. 98, 3, s. 483-484

    Forskningsoutput: TidskriftsbidragLetter

  47. Haplotype analysis of identical factor IX mutants using PCR

    Green, P. M., Montandon, A. J., R. Ljung, Giannelli, F. & Nilsson, I. M., 1992, I : Thrombosis and Haemostasis. 67, 1, s. 66-69

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  48. Heparin binding protein is increased in chronic leg ulcer fluid and released from granulocytes by secreted products of Pseudomonas aeruginosa.

    Lundqvist, K., Heiko Herwald, Sonesson, A. & Artur Schmidtchen, 2004, I : Thrombosis and Haemostasis. 92, 2, s. 281-287

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  49. Heparin-induced osteoporosis in rats

    Mätzsch, T., Bergqvist, D., Hedner, U., Nilsson, B. & Ostergaard, P., 1986, I : Thrombosis and Haemostasis. 56, 3, s. 293-294

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  50. High-dose erythropoietin alters platelet reactivity and bleeding time in rodents in contrast to the neuroprotective variant carbamyl-erythropoietin (CEPO)

    Agnete Kirkeby, Torup, L., Bochsen, L., Kjalke, M., Abel, K., Theilgaard-Monch, K., Johansson, P. I., Bjørn, S. E., Gerwien, J. & Leist, M., 2008 apr, I : Thrombosis and Haemostasis. 99, 4, s. 720-728 9 s.

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  51. High titer inhibitors in severe haemophilia A. A meta-analysis based on eight long-term follow-up studies concerning inhibitors associated with crude or intermediate purity factor VIII products [4]

    Briet, E., Rosendaal, F. R., Kreuz, W., Rasi, V., Peerlinck, K., Vermylen, J., R. Ljung, Rocino, A., Addiego, J. & Lorenzo, J. I., 1994 nov 25, I : Thrombosis and Haemostasis. 72, 1, s. 162-164

    Forskningsoutput: TidskriftsbidragLetter

  52. Homozygous APC-resistance combined with inherited type I protein S deficiency in a young boy with severe thrombotic disease

    Bengt Zöller, He, X. & Björn Dahlbäck, 1995 maj, I : Thrombosis and Haemostasis. 73, 5, s. 743-745 3 s.

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  53. Human tissue factor pathway inhibitor fused to CD4 binds both FXa and TF/FVIIa at the cell surface

    Kristian Riesbeck, Dorling, A., Kemball-Cook, G., McVey, J. H., Jones, M., Tuddenham, E. G. D. & Lechler, R. I., 1997 dec 1, I : Thrombosis and Haemostasis. 78, 6, s. 1488-1494

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  54. Impact, diagnosis and treatment of von Willebrand disease

    Sadler, J. E., Mannucci, P. M., Erik Berntorp, Bochkov, N., Boulyjenkov, V., Ginsburg, D., Meyer, D., Peake, I., Rodeghiero, F. & Srivastava, A., 2000, I : Thrombosis and Haemostasis. 84, 2, s. 160-174

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  55. Increased inhibitor incidence in severe haemophilia A since 1990 attributable to more low titre inhibitors

    van den Berg, H. M., Hashemi, S. M., Fischer, K., Petrini, P., Rolf Ljung, Rafowicz, A., Carcao, M., Auerswald, G., Kurnik, K., Kenet, G. & Santagostino, E., 2016 apr 1, I : Thrombosis and Haemostasis. 115, 4, s. 729-737 9 s.

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  56. Inflammatory role and prognostic value of platelet chemokines in acute coronary syndrome

    Blanchet, X., Cesarek, K., Brandt, J., Heiko Herwald, Teupser, D., Kuechenhoff, H., Karshovska, E., Mause, S. F., Siess, W., Wasmuth, H., Soehnlein, O., Koenen, R. R., Weber, C. & von Hundelshausen, P., 2014, I : Thrombosis and Haemostasis. 112, 6, s. 1277-1287

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  57. Inhibitors in haemophilia A - Prevention, current management and personalised therapy perspectives

    Erik Berntorp, Escuriola-Ettingshausen, C., Khair, K., Kreuz, W., Montano, C. & Zozulya, N., 2011, I : Thrombosis and Haemostasis. 105, 3, s. A4-A14

    Forskningsoutput: TidskriftsbidragDebate/Note/Editorial

  58. INR calibration of Owren-type prothrombin time based on the relationship between PT% and INR utilizing normal plasma samples

    Lindahl, TL., Egberg, N., Andreas Hillarp, Odegaard, OR., Edlund, B., Svensson, J., Sandset, PM. & Ranby, M., 2004, I : Thrombosis and Haemostasis. 91, 6, s. 1223-1231

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  59. Large deletions of the PROS1 gene in a large fraction of mutationnegative patients with protein S deficiency

    Johansson, A., Andreas Hillarp, Torbjörn Säll, Bengt Zöller, Björn Dahlbäck & Halldén, C., 2005, I : Thrombosis and Haemostasis. 94, 5, s. 951-957

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  60. Local INR calibration of the Owren type prothrombin assay greatly improves the intra- and interlaboratory variation. A three-year follow-up from the Swedish national external quality assessment scheme.

    Andreas Hillarp, Egberg, N., Nordin, G., Stigendal, L., Fagerberg, I. & Lindahl, T. L., 2004, I : Thrombosis and Haemostasis. 91, 2, s. 300-307

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  61. Low soluble thrombomodulin activity and antigen is associated with a family history of heart disease while a high level is associated with a personal history of heart disease in type 2 diabetes

    Konstantoulas, C. J., Cooper, J. A., Öhlin, A-K., Humphries, S. E., Goodall, A. H., Toh, C-H., Mather, H. & Ireland, H., 2007, I : Thrombosis and Haemostasis. 97, 1, s. 161-164

    Forskningsoutput: TidskriftsbidragLetter

  62. Management consensus guidance for the use of rivaroxaban - an oral, direct factor Xa inhibitor

    Turpie, A. G. G., Kreutz, R., Llau, J., Bo Norrving & Haas, S., 2012, I : Thrombosis and Haemostasis. 108, 5, s. 876-886

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  63. Modern treatment options for von Willebrand disease and haemophilia B - What are the benefits for the patients?

    Giangrande, P., von Depka, M., Kessler, C. M., Kannicht, C. & Rolf Ljung, 2011, I : Thrombosis and Haemostasis. 106, 3, s. 5-14

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  64. Molecular basis of coagulation factor V deficiency caused by the R1698W inter-domain mutation

    Calzavarini, S., Villoutreix, B. O., Lunghi, B., Livaja Koshiar, R., Bernardi, F. & Björn Dahlbäck, 2013, I : Thrombosis and Haemostasis. 110, 1, s. 31-38

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  65. Mortality rates and risk factors for asymptomatic deep vein thrombosis in medical patients

    Vaitkus, P. T., Leizorovicz, A., Cohen, A. T., Turpie, A. G. G., Olsson, C-G., Goldhaber, S. Z. & G, P. T. S., 2005, I : Thrombosis and Haemostasis. 93, 1, s. 76-79

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  66. Multicentre evaluation of IL Test (TM) Free PS: A fully automated assay to quantify Free Protein S

    Serra, J., Sales, M., Chitolie, A., Domenech, P., Rossi, E., Borrell, M. & Björn Dahlbäck, 2002, I : Thrombosis and Haemostasis. 88, 6, s. 975-983

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  67. Murine monoclonal antibodies against murine uPA receptor produced in gene-deficient mice: inhibitory effects on receptor-mediated uPA activity in vitro and in vivo

    Pass, J., Annika Jögi, Lund, I. K., Rono, B., Rasch, M. G., Gardsvoll, H., Lund, L. R., Ploug, M., Romer, J., Dano, K. & Hoyer-Hansen, G., 2007, I : Thrombosis and Haemostasis. 97, 6, s. 1013-1022

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  68. Next-Generation Sequencing of 17 Genes Associated with Venous Thromboembolism Reveals a Deficit of Non-Synonymous Variants in Procoagulant Genes

    Eric Manderstedt, Lind-Halldén, C., Svensson, P., Bengt Zöller & Halldén, C., 2019 jul 28, I : Thrombosis and Haemostasis.

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  69. No increased risk of venous thrombosis in women taking tranexamic acid

    Erik Berntorp, Follrud, C. & Lethagen, S., 2001, I : Thrombosis and Haemostasis. 86, 2, s. 714-715

    Forskningsoutput: TidskriftsbidragLetter

  70. Obesity/insulin resistance rather than liver fat increases coagulation factor activities and expression in humans

    Lallukka, S., Luukkonen, P. K., Zhou, Y., Isokuortti, E., Leivonen, M., Juuti, A., Hakkarainen, A., Marju Orho-Melander, Lundbom, N., Olkkonen, V. M., Lassila, R. & Yki-Järvinen, H., 2017, I : Thrombosis and Haemostasis. 117, 2, s. 286-294 9 s.

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  71. Old genes and new genes: The evolution of the kallikrein locus.

    Åke Lundwall, 2013, I : Thrombosis and Haemostasis. 109, 6

    Forskningsoutput: TidskriftsbidragÖversiktsartikel

  72. Paracelsus, poison, and colistin

    Heiko Herwald, 2017, I : Thrombosis and Haemostasis. 117, 9, s. 1661 1 s.

    Forskningsoutput: TidskriftsbidragDebate/Note/Editorial

  73. Platelet adhesion in polytetrafluoroethylene (PTFE) vascular grafts in vivo and the influence of increased intramuscular pressure - An experimental model.

    Christensson, J., Qvarfordt, P., Strand, S-E., Arvidsson, D., Trygve Sjöberg & Olsson, P-I., 1983, I : Thrombosis and Haemostasis. 50, 4, s. 881-884

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  74. Platelet Indices and Risk of Death and Cardiovascular Events: Results from a Large Population-Based Cohort Study

    Patti, G., Di Martino, G., Fabrizio Ricci, Renda, G., Gallina, S., Viktor Hamrefors, Olle Melander, Sutton, R., Gunnar Engström, De Caterina, R. & Artur Fedorowski, 2019 nov, I : Thrombosis and Haemostasis. 119, 11, s. 1773-1784

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  75. Platelets: a new target for gene therapy of haemophilia B.

    Brown, M. A., 2002, I : Thrombosis and Haemostasis. 87, 3, s. 362-363

    Forskningsoutput: TidskriftsbidragLetter

  76. Platelets interact with bacterial pathogens.

    Oonagh Shannon, 2009, I : Thrombosis and Haemostasis. 102, 4, s. 613-614

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  77. Pooled analysis of prognostic impact of uPA and PAI-I in breast cancer patients

    Look, M., van Putten, W., Duffy, M., Harbeck, N., Christensen, IJ., Thomssen, C., Kates, R., Spyratos, F., Fernö, M., Eppenberger-Castori, S., Sweep, CGJF., Ulm, K., Peyrat, JP., Martin, PM., Magdelenat, H., Brunner, N., Duggan, C., Lisboa, BW., Bendah, PO., Quillien, V. & 20 andraDaver, A., Ricolleau, G., Meijer-Van Gelder, M., Manders, P., Fiets, WE., Blankenstein, M., Broet, P., Romain, S., Daxenbichler, G., Windbichler, G., Cufer, T., Borstnar, S., Kueng, W., Beex, L., Klijn, J., O'Higgins, N., Eppenberger, U., Janicke, F., Schmitt, M. & Foekens, J., 2003, I : Thrombosis and Haemostasis. 90, 3, s. 538-548

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  78. Practical considerations in choosing a factor VIII prophylaxis regimen: Role of clinical phenotype and trough levels.

    Rolf Ljung, Fischer, K., Carcao, M., Santagostino, E., Manco-Johnson, M. J. & Mathew, P., 2016, I : Thrombosis and Haemostasis. 115, 5, s. 913-920

    Forskningsoutput: TidskriftsbidragÖversiktsartikel

  79. Prophylactic infusion regimens in the management of hemophilia

    R. C R Ljung, 1999, I : Thrombosis and Haemostasis. 82, 2, s. 525-530

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  80. Protein Z and protein Z-dependent protease inhibitor - Determinants of levels and risk of venous thrombosis

    Al-Shanqeeti, A., Vlieg, AV., Erik Berntorp, Rosendaal, FR. & Broze, GJ., 2005, I : Thrombosis and Haemostasis. 93, 3, s. 411-413

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  81. Prothrombin deficiency caused by compound heterozygosity for two novel mutations in the prothrombin gene associated with a bleeding tendency

    Stanchev, H., Philips, M., Villoutreix, BO., Aksglaede, L., Lethagen, S. & Thorsen, S., 2006, I : Thrombosis and Haemostasis. 95, 1, s. 195-198

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  82. Rapid intracellular degradation of a truncated mutant protein S (Q522X)

    Yamazaki, T., Saito, H. & Björn Dahlbäck, 2002, I : Thrombosis and Haemostasis. 87, 1, s. 171-172

    Forskningsoutput: TidskriftsbidragLetter

  83. Rebuttal: Meta-analysis of the relationship of factor V Leiden and intrauterine growth restriction - based on solid evidence?

    Lindqvist, P., Juan Merlo, Dudding, T. & Attia, J., 2005, I : Thrombosis and Haemostasis. 94, 1, s. 230-232

    Forskningsoutput: TidskriftsbidragLetter

  84. Relation between atrial fibrillatory rate and markers of inflammation and haemostasis in persistent human atrial fibrillation

    Tveit, A., Bollmann, A., Seljeflot, I., Husser, D., Martin Stridh, Leif Sörnmo, Arnesen, H., Olsson, S. B. & Smith, P., 2009, I : Thrombosis and Haemostasis. 101, 3, s. 601-603

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  85. Risk Factors for the Progression from Low to High Titres in 260 Children with Severe Haemophilia A and Newly Developed Inhibitors

    Mancuso, M. E., Fischer, K., Santagostino, E., Oldenburg, J., Platokouki, H., Escuriola-Ettingshausen, C., Rivard, G. E., Cid, A. R., Carcao, M., Ljung, R., Petrini, P., Altisent, C., Kenet, G., Kurnik, K., Auerswald, G., Chambost, H., Mäkipernaa, A., Molinari, A. C., Williams, M., van den Berg, H. M. & 1 andraEuropean Pediatric Network for Haemophilia Management (PedNet) the REMAIN (REal life MAnagement of children with INhibitors) Study Group, 2017 dec, I : Thrombosis and Haemostasis. 117, 12, s. 2274-2282

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

Föregående 1 2 Nästa